Summary

Market Overview
The Global Protein Assays Market is anticipated to expand from USD 3.11 billion in 2025 to USD 4.73 billion by 2031, reflecting a compound annual growth rate (CAGR) of 7.24%. These crucial biochemical techniques are widely used to detect, quantify, and characterize proteins in biological samples across basic research, diagnostic testing, and drug development. Market growth is primarily fueled by an intensified emphasis on proteomics, a growing pipeline of biologics and biosimilars, and the broader shift toward personalized medicine. Supporting this trajectory, the World Intellectual Property Organization’s 2024 Global Innovation Index noted that global corporate research and development spending hit about $1.2 trillion in 2023, accompanied by a 10% year-over-year increase in pharmaceutical R&D investments.
Even with these strong growth catalysts, the market faces notable hurdles that could slow its advancement. The need for significant upfront financial investments in sophisticated equipment, coupled with the necessity for highly trained personnel to execute complex procedures and analyze difficult data, remains a prominent barrier to widespread expansion.
Market Driver
Rising research and development investments in the pharmaceutical and biotechnology sectors are major catalysts for the Global Protein Assays Market, accelerating the discovery and validation of novel drug targets. These assays serve as vital instruments across all phases of drug development?from initial discovery to clinical testing?enabling the assessment of protein interactions, biomarker identification, and therapeutic efficacy. For example, Johnson & Johnson’s Q4 2025 Earnings Report (January 2026) highlighted a full-year R&D spend of $14.7 billion, reflecting a deep commitment to innovation that fuels the need for advanced protein analysis tools. Such sustained financial backing guarantees a steady flow of prospective therapies that all depend on comprehensive protein evaluation.
The continued growth of the biopharmaceutical sector acts as another primary market driver, as it heavily relies on accurate protein measurement for product creation, quality assurance, and strict regulatory adherence. Manufacturing protein-based treatments like biologics and biosimilars requires constant oversight to guarantee safety, strength, and purity at every production phase. As reported by the Association of the British Pharmaceutical Industry on May 20, 2025, BioNTech pledged up to ?1 billion over a decade to grow its UK footprint, illustrating scaling initiatives that naturally boost protein assay usage. Additionally, a July 2025 Biotechnology Innovation Organization report showed biotech startups secured $2.6 billion during the first quarter of the year, emphasizing the escalating financial support for protein analysis technologies throughout the life sciences field.
Market Challenge
The steep capital requirements for state-of-the-art equipment present a direct obstacle to the expansion of the Global Protein Assays Market. Purchasing advanced platforms, including automated liquid handlers and mass spectrometers, involves hefty initial expenses that form major financial roadblocks for smaller research facilities and newer biotech firms. This economic pressure restricts the integration of next-generation tools necessary for thorough protein evaluation. Highlighting this cautious spending environment, a 2023 survey by Lab Manager revealed that a mere 35 percent of respondents expected their budgets for both new and used laboratory equipment to grow in 2024. Such constrained funding limits the ability of labs to upgrade their technology and broaden their assay capacities.
Adding to these financial hurdles is the intense need for highly trained experts who can run these complex machines and decipher intricate analytical data. A shortage of skilled personnel proficient in high-level protein assays and bioinformatics drives up daily operating expenses, driven by the need for lengthy training programs and premium salaries. Ultimately, the combined weight of massive upfront costs and the struggle to secure specialized talent curtails broader market growth by raising the overall expense and restricting access to these indispensable scientific resources.
Market Trends
The creation of multiplexed and high-throughput assay systems is a defining trend transforming the Global Protein Assays Market, allowing researchers to evaluate multiple protein targets across numerous samples simultaneously. This leap in technology vastly improves the speed of protein characterization, which is essential for massive proteomics initiatives and pharmaceutical discovery. Processing larger datasets while using fewer reagents and smaller sample volumes helps decrease individual sample costs and speeds up research cycles. For instance, Proteomics Industry News reported in February 2025 that the UK Biobank Pharma Proteomics Project intends to measure over 5,400 proteins in 600,000 samples utilizing systems like Thermo Fisher Scientific’s Orbitrap Ascend Ultra. This emphasis on multiplexing perfectly aligns with the surging need for fast, thorough protein profiling in both clinical and research settings.
Another revolutionary trend is the incorporation of machine learning and artificial intelligence into assay evaluation, which elevates traditional data handling into advanced predictive modeling. By recognizing intricate patterns within the massive datasets produced by protein assays, AI and ML technologies enhance precision, clear analytical logjams, and uncover unseen drug targets and biomarkers. This shift allows for more accurate quantification, automated quality checks, and enriched insights into cellular networks. Highlighting this trend, Benzinga reported in April 2026 that the PRECISE-SG100K study is leveraging Seer Inc.’s Proteograph Product Suite alongside other technologies to map the plasma proteomes of 10,000 individuals, ultimately accelerating biomarker detection. These smart analytical instruments are critical for maximizing the utility of complex assay data, driving progress in biopharmaceuticals and targeted therapies.

Key Market Players
* Becton Dickinson and Co
* Thermo Fisher Scientific Inc.
* Bio-Rad Laboratories Inc
* Merck KGaA
* Abcam PLC
* PerkinElmer Inc.
* QIAGEN NV
* Lonza Group AG
* Bio-Techne Corp
* Illumina Inc

Report Scope
In this report, the Global Protein Assays Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

# Protein Assays Market , By Type
* Dye Binding Assays
* Test Strip-Based Assays
* Copper-Ion-Based Assays
* Others
# Protein Assays Market , By Product
* Reagents
* Kits
* Instruments
* Accessories
# Protein Assays Market , By Technology
* Colorimetric Protein Assays
* Fluorescence-Based Protein Assays
* Absorbance-Based Protein Assays
# Protein Assays Market , By Application
* Drug Discovery and Development
* Disease Diagnosis
* Others
# Protein Assays Market , By End User
* Pharmaceutical and Biotechnology Companies
* Clinical Laboratories
* Hospitals
* Academic Research Institutes
* Others
# Protein Assays Market , By Region
* North America
United States
Canada
Mexico
* Europe
France
United Kingdom
Italy
Germany
Spain
* Asia Pacific
China
India
Japan
Australia
South Korea
* South America
Brazil
Argentina
Colombia
* Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Protein Assays Market .
Available Customizations:
Global Protein Assays Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
* Detailed analysis and profiling of additional market players (up to five).

ページTOPに戻る

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Protein Assays Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Dye Binding Assays, Test Strip-Based Assays, Copper-Ion-Based Assays, Others)
5.2.2. By Product (Reagents, Kits, Instruments, Accessories)
5.2.3. By Technology (Colorimetric Protein Assays, Fluorescence-Based Protein Assays, Absorbance-Based Protein Assays)
5.2.4. By Application (Drug Discovery and Development, Disease Diagnosis, Others)
5.2.5. By End User (Pharmaceutical and Biotechnology Companies, Clinical Laboratories, Hospitals, Academic Research Institutes, Others)
5.2.6. By Region
5.2.7. By Company (2025)
5.3. Market Map
6. North America Protein Assays Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Product
6.2.3. By Technology
6.2.4. By Application
6.2.5. By End User
6.2.6. By Country
6.3. North America: Country Analysis
6.3.1. United States Protein Assays Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Product
6.3.1.2.3. By Technology
6.3.1.2.4. By Application
6.3.1.2.5. By End User
6.3.2. Canada Protein Assays Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Product
6.3.2.2.3. By Technology
6.3.2.2.4. By Application
6.3.2.2.5. By End User
6.3.3. Mexico Protein Assays Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Product
6.3.3.2.3. By Technology
6.3.3.2.4. By Application
6.3.3.2.5. By End User
7. Europe Protein Assays Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Product
7.2.3. By Technology
7.2.4. By Application
7.2.5. By End User
7.2.6. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Protein Assays Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Product
7.3.1.2.3. By Technology
7.3.1.2.4. By Application
7.3.1.2.5. By End User
7.3.2. France Protein Assays Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Product
7.3.2.2.3. By Technology
7.3.2.2.4. By Application
7.3.2.2.5. By End User
7.3.3. United Kingdom Protein Assays Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Product
7.3.3.2.3. By Technology
7.3.3.2.4. By Application
7.3.3.2.5. By End User
7.3.4. Italy Protein Assays Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Product
7.3.4.2.3. By Technology
7.3.4.2.4. By Application
7.3.4.2.5. By End User
7.3.5. Spain Protein Assays Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Product
7.3.5.2.3. By Technology
7.3.5.2.4. By Application
7.3.5.2.5. By End User
8. Asia Pacific Protein Assays Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Product
8.2.3. By Technology
8.2.4. By Application
8.2.5. By End User
8.2.6. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Protein Assays Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Product
8.3.1.2.3. By Technology
8.3.1.2.4. By Application
8.3.1.2.5. By End User
8.3.2. India Protein Assays Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Product
8.3.2.2.3. By Technology
8.3.2.2.4. By Application
8.3.2.2.5. By End User
8.3.3. Japan Protein Assays Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Product
8.3.3.2.3. By Technology
8.3.3.2.4. By Application
8.3.3.2.5. By End User
8.3.4. South Korea Protein Assays Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Product
8.3.4.2.3. By Technology
8.3.4.2.4. By Application
8.3.4.2.5. By End User
8.3.5. Australia Protein Assays Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Product
8.3.5.2.3. By Technology
8.3.5.2.4. By Application
8.3.5.2.5. By End User
9. Middle East & Africa Protein Assays Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Product
9.2.3. By Technology
9.2.4. By Application
9.2.5. By End User
9.2.6. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Protein Assays Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Product
9.3.1.2.3. By Technology
9.3.1.2.4. By Application
9.3.1.2.5. By End User
9.3.2. UAE Protein Assays Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Product
9.3.2.2.3. By Technology
9.3.2.2.4. By Application
9.3.2.2.5. By End User
9.3.3. South Africa Protein Assays Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Product
9.3.3.2.3. By Technology
9.3.3.2.4. By Application
9.3.3.2.5. By End User
10. South America Protein Assays Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Product
10.2.3. By Technology
10.2.4. By Application
10.2.5. By End User
10.2.6. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Protein Assays Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Product
10.3.1.2.3. By Technology
10.3.1.2.4. By Application
10.3.1.2.5. By End User
10.3.2. Colombia Protein Assays Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Product
10.3.2.2.3. By Technology
10.3.2.2.4. By Application
10.3.2.2.5. By End User
10.3.3. Argentina Protein Assays Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Product
10.3.3.2.3. By Technology
10.3.3.2.4. By Application
10.3.3.2.5. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Protein Assays Market : SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Becton Dickinson and Co
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Thermo Fisher Scientific Inc.
15.3. Bio-Rad Laboratories Inc
15.4. Merck KGaA
15.5. Abcam PLC
15.6. PerkinElmer Inc.
15.7. QIAGEN NV
15.8. Lonza Group AG
15.9. Bio-Techne Corp
15.10. Illumina Inc
16. Strategic Recommendations
17. About Us & Disclaimer